Division of Novartis AG
Latest From Endocyte Inc.
R&D head John Tsai spoke with Scrip about culture change at Novartis as it moves toward advanced therapy platforms and embraces digital technologies, and offered a peek into what’s in store for R&D in 2019 and beyond.
A look back at the Scrip stories that piqued the most interest for our readers in 2018.
Liz Barrett leaves her fresh role as head of Novartis Oncology, leaving AAA President Susanne Schaffert to fill the gap.
At Novartis’s first R&D day since he took the helm, new CEO Vas Narasimhan told Scrip about how the company plans to build value through its newly acquired breakthrough technologies and what deals it is looking for next.
- In Vitro Diagnostics
- Diagnostic Imaging Equipment & Supplies
- Drug Delivery
- Radiopharmaceuticals, Contrast Agents
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Novartis AG
- Senior Management
Michael A Sherman, Pres. & CEO
Michael T Andriole, CFO
Matthew Call, VP, Bus. Dev. & Mktg.
Philip S Low, PhD, CSO
Alison A Armour, MD, CMO
- Contact Info
Phone: (765) 463-7175
3000 Kent Ave.
West Lafayette, IN 47906
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.